FDA Approves METFORMIN HYDROCHLORIDE — Viona Pharmaceuticals Inc
Viona Pharmaceuticals Inc. has confirmed the approval of its Abbreviated New Drug Application for METFORMIN HYDROCHLORIDE (ANDA077060), a critical oral treatment for type 2 diabetes. This clearance reinforces the competitive landscape of the generic market while providing a stable supply of essential therapy.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed